HUP1100241A3 - Oxetane substituted pyrimidones - Google Patents

Oxetane substituted pyrimidones

Info

Publication number: HUP1100241A3
Authority: HU; Hungary
Prior art keywords: oxetane substituted; substituted pyrimidones; pyrimidones; oxetane; substituted
Prior art date: 2011-05-06

Application number

HU1100241A

Other languages

Hungarian (hu)

Original Assignee

Richter Gedeon Nyrt

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-05-06

Filing date

2011-05-06

Publication date

2013-12-30

2011-05-06 Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt

2011-05-06 Priority to HU1100241A priority Critical patent/HUP1100241A3/en

2012-05-04 Priority to PCT/HU2012/000032 priority patent/WO2012153154A1/en

2012-12-28 Publication of HUP1100241A2 publication Critical patent/HUP1100241A2/en

2013-12-30 Publication of HUP1100241A3 publication Critical patent/HUP1100241A3/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Hematology (AREA)
Diabetes (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

HU1100241A 2011-05-06 2011-05-06 Oxetane substituted pyrimidones HUP1100241A3 (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
HU1100241A HUP1100241A3 (en)	2011-05-06	2011-05-06	Oxetane substituted pyrimidones
PCT/HU2012/000032 WO2012153154A1 (en)	2011-05-06	2012-05-04	Oxetane substituted thieno pyrimidinones

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
HU1100241A HUP1100241A3 (en)	2011-05-06	2011-05-06	Oxetane substituted pyrimidones

Publications (2)

Publication Number	Publication Date
HUP1100241A2 HUP1100241A2 (en)	2012-12-28
HUP1100241A3 true HUP1100241A3 (en)	2013-12-30

Family

ID=89990277

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU1100241A HUP1100241A3 (en)	2011-05-06	2011-05-06	Oxetane substituted pyrimidones

Country Status (2)

Country	Link
HU (1)	HUP1100241A3 (en)
WO (1)	WO2012153154A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP6669499B2 (en) *	2013-02-15	2020-03-18	カラファーマシューティカルズインコーポレイテッド	Therapeutic compounds
MX379159B (en)	2016-02-12	2025-03-10	Astellas Pharma Inc	TETRAHYDROISOQUINOLINE DERIVATIVES.
CN113045523B (en) *	2019-12-27	2022-09-23	上海泓博智源医药股份有限公司	Preparation method of imidazoline pyridine compound intermediate

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1169027A (en)	1966-11-19	1969-10-29	Beecham Group Ltd	Azetidine Derivatives
GB0124627D0 (en)	2001-10-15	2001-12-05	Smithkline Beecham Plc	Novel compounds
EP1618112A1 (en)	2003-04-11	2006-01-25	SmithKline Beecham Corporation	Heterocyclic mchr1 antagonists
US20070078125A1 (en)	2003-10-23	2007-04-05	Glaxo Group Limited	Arylamine mch r1 antagonists
US20050176738A1 (en)	2003-11-07	2005-08-11	Neurocrine Biosciences, Inc.	Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
EP1876179B1 (en)	2005-04-28	2015-03-25	Takeda Pharmaceutical Company Limited	Thienopyrimidone compounds
JP2009501217A (en)	2005-07-15	2009-01-15	アストラゼネカアクチボラグ	Remedy
WO2007011286A1 (en)	2005-07-15	2007-01-25	Astrazeneca Ab	Therapeutic agents
US7745447B2 (en)	2005-10-26	2010-06-29	Bristol-Myers Squibb Company	Substituted thieno[3,2-D]pyrimidines as non-basic melanin concentrating hormone receptor-1 antagonists
US8618115B2 (en)	2005-10-26	2013-12-31	Bristol-Myers Squibb Company	Substituted thieno[3,2-d]pyrimidinones as MCHR1 antagonists and methods for using them
CA2636879A1 (en)	2006-02-15	2007-08-23	Sanofi-Aventis	Novel amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
CA2636605A1 (en)	2006-02-15	2007-08-23	Lothar Schwink	Novel azacycly-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
WO2008002575A1 (en)	2006-06-26	2008-01-03	The Procter & Gamble Company	Melanin concentrating hormone antagonists
WO2008020799A1 (en)	2006-08-18	2008-02-21	Astrazeneca Ab	Thienopyrimidin-4-one and thienopyridazin-7-one derivatives as mch rl antagonists
WO2008131103A2 (en)	2007-04-17	2008-10-30	Vertex Pharmaceuticals Incorporated	Drug discovery methods for aurora kinase inhibitors

2011
- 2011-05-06 HU HU1100241A patent/HUP1100241A3/en unknown
2012
- 2012-05-04 WO PCT/HU2012/000032 patent/WO2012153154A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO2012153154A1 (en)	2012-11-15
HUP1100241A2 (en)	2012-12-28

Publication	Publication Date	Title
DK3798230T3 (en)	2022-10-31	Terapeutiske antistoffer
DK2691417T4 (en)	2025-01-02	Antistof fc-varianter
EP2755962A4 (en)	2015-04-15	Azaindazoles
EP2754063A4 (en)	2015-08-05	Smb2 scaleout
EP2776444A4 (en)	2015-07-22	Dihydropteridinones
AP2014007621A0 (en)	2014-05-31	2-Thiopyrimidinones
EP2658720A4 (en)	2016-03-02	Printing
EP2663331A4 (en)	2015-07-15	Novel uses
EP2695208A4 (en)	2014-12-31	Micro-thermocouple
GB201119167D0 (en)	2011-12-21	Novel bachteriophages
IL227377A0 (en)	2013-09-30	Combinations
DK2770906T3 (en)	2021-02-22	Applanationstonometer
HUP1100241A3 (en)	2013-12-30	Oxetane substituted pyrimidones
GB201107672D0 (en)	2011-06-22	Ink
GB201101727D0 (en)	2011-03-16	Obuoy
GB201100001D0 (en)	2011-02-16	TidySqueeze2
AU4540P (en)	2013-05-16	BUNNAN Baloskion tetraphyllum
AU5026P (en)	2015-06-03	Goldstrike Agapanthus inapertus
AU5031P (en)	2015-06-04	BESYS Beschorneria yuccoides
AU5171P (en)	2015-11-23	Sunparamiho Mandevilla xamabilis
GB201102529D0 (en)	2011-03-30	Fine B-Day
GB201113923D0 (en)	2011-09-28	Novel combinations
GB201107854D0 (en)	2011-06-22	Novel 5-hydroxy-5-aryl-pyrrol-2-ones
GB201111983D0 (en)	2011-08-31	Improved ink
GB201100828D0 (en)	2011-03-02	Printing

Legal Events

Date	Code	Title	Description
2014-08-28	FA9A	Lapse of provisional patent protection due to relinquishment or protection considered relinquished